Followers | 48 |
Posts | 1181 |
Boards Moderated | 0 |
Alias Born | 04/20/2018 |
Tuesday, May 22, 2018 1:30:50 PM
I have had an opportunity to launch new products throughout my career. Having a smart, well thought out plan and executing to that plan are what give you the best chance for success.
The AUA conference just ended. My belief is the CMTH team are busy behind the scenes digesting data, getting doctors contracts and orders together, getting a sales team mobilized and thus executing on Caverstem commercialization. There are a lot of moving pieces happening quickly. They will put a PR out when they have their ducks in a row. Not because someone on an IHUB board thinks they should right now.
I applaud ES for putting his money and actions to the benefit of all. I added 300K more this morning not at $.015 but an average of $.017. The AWP of my shares is $.0184 on over 4M. For those of you who want to see CMTH (CELZ) be all it can be, start by giving them some grace on PR's and buy shares at market rates and put your money towards helping the cause. Don't flip when it goes to $.027 or higher on next run. Hold those shares if you truly believe in what they are working to accomplish. And don't listen to people bashing on the board. They don't have any inside info and just want cheap shares to flip. They are not interested in anyone but themselves and could care less about the company.
Let the CEO, COO and CFO know through email you are an investor who support their efforts. Provide your suggestions and/or concerns. But don't expect an immediate response as I'm sure they are all very busy.
Be patient! Stop incessantly posting and let the company do it's thing. This is not J&J or Pfizer with 1,000's of employees to execute a new product introduction. This is a small, flexible group that is working diligently to do things the right way.
My belief is it will pay off but it takes time. Until CMTH leadership show me they are not doing things the right way, I'm going to keep my shares and ride this wave over the next few months to see where it goes.
The CEO purchased $140K worth of his own shares at a price higher than the market on that date. He did not do this to give away money. He knows their numerous patents coupled with commercialization of Caverstem will pay off in due time.
Enjoy the day and good luck to you all.
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM